Lawmakers blast Valeant for price-gouging tactics

WASHINGTON (AP) — Lawmakers accused Valeant Pharmaceuticals of gouging patients to reward Wall Street investors during a hearing Wednesday scrutinizing the embattled drugmaker's pricing tactics.